Torrent Pharma Announces 53rd AGM on June 23, 2026, via VC/OAVM
Torrent Pharmaceuticals Limited will hold its 53rd Annual General Meeting on June 23, 2026. The meeting will take place at 09:30 a.m. via Video Conferencing / Other Audio Visual Means (VC / OAVM). This announcement was published on May 28, 2026.
The announcement is a standard procedural update regarding the company's AGM, which is a regular annual event. It does not contain new material information that would significantly affect the company's operations or stock.
The announcement is a routine intimation regarding the Annual General Meeting and does not contain any financial performance data or strategic decisions that would impact the sentiment.
Torrent Pharmaceuticals Limited has announced that its 53rd Annual General Meeting (AGM) will be held on Tuesday, June 23, 2026, at 09:30 a.m. The meeting will be conducted through Video Conferencing / Other Audio Visual Means (VC / OAVM) facility.
This intimation was published in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and various circulars issued by the Ministry of Corporate Affairs. The advertisements were published in Financial Express (English) and Financial Express (Gujarati) on May 28, 2026.
The company has provided contact information for investor services via email at investorservices@torrentpharma.com.
What to do with a filing like this
Torrent Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Torrent Pharmaceuticals Limited. Read the original for the full detail.